Researchers find similar drug development to reimbursement timelines for major markets
<p>Time between a drug’s entry into clinical trials and its approval for reimbursement was similar in four major markets, according to a cross-sectional analysis published in JAMA Health Forum.</p>
27 Jul 2026 EMA says it takes ultimate responsibility for protecting online meeting registration, survey information The European Medicines Agency (EMA) has issued notices stating how it will comply with certain stakeholder information protection under the Data Protection Regulation for EU institutions, bodies, offices, and agencies (EUDPR). Under the regulation that went into effect in 2018, also known as EU 2018/1725, the agency said it is responsible for managing and protecting information received from stakeholders through registration forms and online surveys. Regulatory News
comments(0)
5-min edit window · permanent after that